DUBLIN--(BUSINESS WIRE)--The "Dialysis Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering. Where is the largest and fastest growing market for ...

Irvine-based Diality Inc., a maker of a medical device to treat kidney diseases, raised $28 million in its latest funding round to support the company’s effort to bring to market what it calls a ...

This article is part of a series of profiles on the 2020 winners of the National Academy of Medicine’s Healthy Longevity Catalyst Awards — part of the Healthy Longevity Global Competition, a multiyear ...

Please provide your email address to receive an email when new articles are posted on . Researchers asked the nephrologists and nurses questions about ideal features, barriers and design parameters, ...

Please provide your email address to receive an email when new articles are posted on . The Quanta Dialysis device supports two modes of continuous renal replacement therapy. It provides dialysate ...

The week after President Donald Trump signed a landmark executive order meant to overhaul the current kidney care system, CVS Health has launched a clinical trial for HemoCare, an at-home hemodialysis ...

HUS Helsinki University Hospital and VTT are starting a field test of wearable sensors to develop home dialysis. A total of 36 volunteer patients will use the sensors that enable monitoring of ...

A new device for the percutaneous creation of an arteriovenous fistula (AVF) for hemodialysis access in patients with kidney disease has excellent cumulative patency rates out to 2 years and is ...

CVS Health launched a long-awaited trial to test out its at-home dialysis device designed to provide more frequent and thorough treatments compared to those offered in the clinic. The nationwide ...

CVS is lauching a clinical trial for a new device that would allow patients with kidney disease to receive dialysis at home; in response to the Trump administration's family planning rule, Planned ...

A liver dialysis device has been demonstrated as safe and effective for treating severe liver failure in the first in-patient trial. It is estimated that globally there are around 100 million people ...

Globally, more than four million ESRD patients receive approximately 640 million dialysis treatments each year. Once on dialysis, their median length of survival is 3-5 years. Cardiovascular disease ...